Endothelin-1 Mediates Oxaliplatin Resistance via Activation of YAP Signaling in Colorectal Cancer
Ranran Yang(Sun Yat-sen University), Hong Zhang(Shanghai Jiao Tong University), Yingqi Zhang(Zhejiang Lab), Qinghai Li(Shandong University of Science and Technology), Jie Huang(Sun Yat-sen University), Weiling He(Sun Yat-sen University), Dan Yuan(Shandong Eye Hospital), Siying Zhu(Sun Yat-sen University)
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
January 1, 2025
Cited by 2
Related Papers
Lung Adenocarcinoma Harboring EGFR T790M and In Trans C797S Responds to Combination Therapy of First- and Third-Generation EGFR TKIs and Shifts Allelic Configuration at Resistance
|Journal of Thoracic Oncology|2017|220
A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance
|Theranostics|2020|110
Phase II Randomized Trial of Autologous Formalin-Fixed Tumor Vaccine for Postsurgical Recurrence of Hepatocellular Carcinoma
|Clinical Cancer Research|2004|97